Diosmetin augments BRAF-targeted therapy via concurrent suppression of MAPK and STAT3 pathways in melanoma

作者：Jiashe Chen, Yulin Liang, Jie Li, Fei Wu, Nanhui Wu, Shuyi Liu, Shuyi Liu, Qi Yu, Yueyi Zhu, Mingyuan Xu, Xiaoxiang Xu, Yeqiang Liu · 发表于：European Journal of Pharmacology · 年份：2025 · DOI：10.1016/j.ejphar.2025.178008 · 被引用次数：4 · 研究领域：Melanoma and MAPK Pathways、Cancer Mechanisms and Therapy、Cytokine Signaling Pathways and Interactions